| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 19.417 | 21.868 | 21.168 | 22.946 | 26.453 | 31.664 | 16.733 | 2.573 |
| Total Income - EUR | - | - | 19.418 | 21.868 | 21.168 | 24.947 | 26.455 | 31.664 | 16.733 | 2.573 |
| Total Expenses - EUR | - | - | 6.322 | 11.230 | 13.832 | 13.373 | 14.450 | 14.157 | 8.138 | 6.450 |
| Gross Profit/Loss - EUR | - | - | 13.096 | 10.638 | 7.336 | 11.574 | 12.005 | 17.506 | 8.595 | -3.877 |
| Net Profit/Loss - EUR | - | - | 12.513 | 9.982 | 6.700 | 10.922 | 11.211 | 16.556 | 7.152 | -3.877 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nanomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 28.195 | 19.739 | 12.651 | 5.157 | 3.147 | 4.657 | 7.551 |
| Current Assets | - | - | 14.977 | 2.573 | 10.749 | 28.335 | 43.234 | 34.690 | 7.845 | 1.081 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.950 | 1.692 | 421 | 1.762 | 5.345 | 13.921 | 801 | 680 |
| Cash | - | - | 12.028 | 881 | 10.327 | 26.572 | 37.889 | 20.769 | 7.044 | 401 |
| Shareholders Funds | - | - | 12.557 | 20.159 | 26.469 | 36.890 | 47.283 | 16.597 | 12.347 | 4.381 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.420 | 10.609 | 4.018 | 4.096 | 1.108 | 21.240 | 154 | 4.251 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nanomed Srl